---
title: "SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292772090.md"
description: "SciSparc Ltd. announced that its subsidiary, NeuroThera Labs Inc., has initiated a Phase IIb clinical trial at Hannover Medical School in Germany. The trial evaluates SCI-110, a cannabinoid-based treatment for Tourette Syndrome in adults. This development marks a significant advancement in researching therapies for the disorder."
datetime: "2026-07-15T12:43:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292772090.md)
  - [en](https://longbridge.com/en/news/292772090.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292772090.md)
---

# SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

TEL AVIV, Israel, July 15, 2026 - SciSparc Ltd. revealed that its branch NeuroThera Labs Inc. has started its Phase IIb clinical trial site at Hannover Medical School in Hanover, Germany for SCI-110, a cannabinoid-based treatment for Tourette Syndrome in adults. NeuroThera Labs, a clinical-stage pharmaceutical company under SciSparc, is dedicated to developing innovative therapies for central nervous system conditions. The commencement of the trial marks a significant advancement in the research for treating TS, and signifies a crucial step towards potentially offering relief to those affected by the disorder.

### Related Stocks

- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)

## Related News & Research

- [SciSparc targets agentic AI market as new growth strategy](https://longbridge.com/en/news/294213778.md)
- [Accenture Earnings Preview: What to Expect](https://longbridge.com/en/news/294039989.md)
- [Otsuka wins FDA approval for Simtriyo ADHD treatment in adults, children 6+](https://longbridge.com/en/news/293807164.md)
- [Generational Group Advises Lampert's Home Therapy, Inc. in its Sale to a Private Investor](https://longbridge.com/en/news/294091391.md)
- [10:31 ETFood Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight](https://longbridge.com/en/news/293947697.md)